MX2021007551A - Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas. - Google Patents
Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas.Info
- Publication number
- MX2021007551A MX2021007551A MX2021007551A MX2021007551A MX2021007551A MX 2021007551 A MX2021007551 A MX 2021007551A MX 2021007551 A MX2021007551 A MX 2021007551A MX 2021007551 A MX2021007551 A MX 2021007551A MX 2021007551 A MX2021007551 A MX 2021007551A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- sup
- neurodegenerative diseases
- bile acids
- fluorinated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Compuestos de ácido biliar 2-Fluorinado de fórmula general (I) (ver Fórmula) en donde al menos uno de R1 y R2 representa F y el otro se elige 3 de H y F y en donde R3 es como se define en la presente; son de uso en el tratamiento y prevención de trRastornos neurodegenerativos que incluyen enfermedad de Alzheimer y enfermedad de Parkinson.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1820887.6A GB201820887D0 (en) | 2018-12-20 | 2018-12-20 | Compounds |
PCT/GB2019/053665 WO2020128514A1 (en) | 2018-12-20 | 2019-12-20 | 2-fluorinated bile acids for the treatment of neurodegenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021007551A true MX2021007551A (es) | 2021-10-13 |
Family
ID=65364420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021007551A MX2021007551A (es) | 2018-12-20 | 2019-12-20 | Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20220073557A1 (es) |
EP (1) | EP3898645A1 (es) |
JP (1) | JP2022514401A (es) |
KR (1) | KR20210125982A (es) |
CN (1) | CN113330020B (es) |
AU (1) | AU2019411556A1 (es) |
BR (1) | BR112021011189A2 (es) |
CA (1) | CA3123333A1 (es) |
EA (1) | EA202191521A1 (es) |
GB (1) | GB201820887D0 (es) |
IL (1) | IL284093A (es) |
MX (1) | MX2021007551A (es) |
SG (1) | SG11202105465WA (es) |
WO (1) | WO2020128514A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202208151D0 (en) | 2022-06-01 | 2022-07-13 | Nzp Uk Ltd | Compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2934596B1 (fr) * | 2008-07-30 | 2015-04-10 | Trophos | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation |
WO2014036379A2 (en) * | 2012-08-31 | 2014-03-06 | Metselex | Bile acids prevent or abolish progression of parkinson's and related neurodegenerative diseases |
US20150112089A1 (en) | 2013-10-22 | 2015-04-23 | Metselex, Inc. | Deuterated bile acids |
WO2016145216A1 (en) | 2015-03-10 | 2016-09-15 | Metselex, Inc. | Fluorinated and alkylated bile acids |
-
2018
- 2018-12-20 GB GBGB1820887.6A patent/GB201820887D0/en not_active Ceased
-
2019
- 2019-12-20 US US17/415,216 patent/US20220073557A1/en active Pending
- 2019-12-20 CA CA3123333A patent/CA3123333A1/en active Pending
- 2019-12-20 SG SG11202105465WA patent/SG11202105465WA/en unknown
- 2019-12-20 EA EA202191521A patent/EA202191521A1/ru unknown
- 2019-12-20 JP JP2021535715A patent/JP2022514401A/ja active Pending
- 2019-12-20 BR BR112021011189-1A patent/BR112021011189A2/pt unknown
- 2019-12-20 KR KR1020217019166A patent/KR20210125982A/ko unknown
- 2019-12-20 CN CN201980085276.5A patent/CN113330020B/zh active Active
- 2019-12-20 WO PCT/GB2019/053665 patent/WO2020128514A1/en unknown
- 2019-12-20 MX MX2021007551A patent/MX2021007551A/es unknown
- 2019-12-20 AU AU2019411556A patent/AU2019411556A1/en active Pending
- 2019-12-20 EP EP19831850.3A patent/EP3898645A1/en active Pending
-
2021
- 2021-06-16 IL IL284093A patent/IL284093A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL284093A (en) | 2021-08-31 |
CN113330020A (zh) | 2021-08-31 |
EP3898645A1 (en) | 2021-10-27 |
US20220073557A1 (en) | 2022-03-10 |
EA202191521A1 (ru) | 2021-09-10 |
BR112021011189A2 (pt) | 2021-08-31 |
WO2020128514A1 (en) | 2020-06-25 |
JP2022514401A (ja) | 2022-02-10 |
AU2019411556A1 (en) | 2021-06-10 |
KR20210125982A (ko) | 2021-10-19 |
CN113330020B (zh) | 2024-04-05 |
CA3123333A1 (en) | 2020-06-25 |
GB201820887D0 (en) | 2019-02-06 |
SG11202105465WA (en) | 2021-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022016276A (es) | Nuevos profarmacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson. | |
PH12018500087A1 (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors | |
MX2016014634A (es) | Compuestos para el tratamiento de enfermedades y trastornos oftalmicos. | |
MX2019013561A (es) | Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos. | |
WO2009127642A3 (en) | Use of lrrk2 inhibitors for neurodegenerative diseases | |
MX2017006049A (es) | 2-amino-6-(difluorometil)-5,5-difluoro-6-fenil-3,4,5,6-tetrahidro piridinas como inhibidores de bace1. | |
EA200971050A1 (ru) | Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений | |
UA88634C2 (en) | Quaternized quinuclidine esters | |
EA201990450A1 (ru) | Ингибиторы киназы, содержащей домен с двумя лейциновыми "застежками-молниями" (dlk), для лечения заболевания | |
EA200601607A1 (ru) | Сульфонамидные соединения для лечения нейродегенеративных расстройств | |
WO2019224790A3 (en) | Prodrugs of fulvestrant | |
MX2019007101A (es) | Derivados de oxazina como inhibidores de beta secretasa y metodos de uso. | |
WO2019075456A3 (en) | Methods and substances for prevention and treatment of neurodegenerative diseases | |
MX2021007551A (es) | Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas. | |
CR20210499A (es) | Compuestos y composiciones como moduladores de la señalización de tlr | |
DE602005007912D1 (de) | Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten | |
MX2010002765A (es) | Derivado de 6-pirimidinil-pirimid-4-ona. | |
MX2020013689A (es) | Hidroxipropil-?-ciclodextrina novedosa y proceso para la producción de esta. | |
MX2019013562A (es) | Compuestos de anilina heteroaromatica o fusionados para el tratamiento de trastornos dermicos. | |
EA201890460A1 (ru) | Композиции и способы лечения и предотвращения нейродегенеративных расстройств | |
RS20080139A (en) | Imidazole coumpounds for the treatment of neurological disorders | |
MX2022011697A (es) | Inhibidores de ciclofilina y usos de los mismos. | |
MX2021011574A (es) | Nuevos compuestos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios. | |
MX2020005238A (es) | Compuestos novedosos como inhibidores mpges-1. | |
GEP20237493B (en) | Use of malonic acid bisamide derivative for treating allergic and other diseases in humans and animals |